◆英語タイトル：Noevir Holdings Co Ltd (4928) - Financial and Strategic SWOT Analysis Review
◆レポート形式：英語 / PDF
Noevir Holdings Co Ltd (4928) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Noevir Holdings Co., Ltd. (Noevir Holdings), through its subsidiaries manufactures and markets skincare, pharmaceuticals and health food products. It comprise of beauty serums, cleansing milk, cleansing water, skin lotions, moisturizing gel, moisturizing sheet mask and face lotions. In addition, it offers cough drops, functional drinks, over the counter (OTC) pharmaceuticals, cold remedies, eye drops and other untritional supplements. These products are marketed under excel, Noevir, Nameraka Honpo, NOV, Min Min Da Ha and Nanten Nodo Ame, to mention a few. Noevir Holdings merchandises and sells various through various sales channels that include drug stores, general retailers, specialty goods stores, general merchandise stores (GMS), supermarkets, contract manufacturing stores and convenience stores at various affordable prices across various domestic and international markets. The company is headquartered in Tokyo, Japan.
Noevir Holdings Co Ltd Key Recent Developments
Aug 03,2017: Noevir Holdings Announces Consolidated Results for the First Nine Months of the Fiscal Year Ending September 30, 201 7
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Section 1 – About the Company 5
Noevir Holdings Co Ltd – Key Facts 5
Noevir Holdings Co Ltd – Key Employees 6
Noevir Holdings Co Ltd – Major Products and Services 7
Noevir Holdings Co Ltd – History 8
Noevir Holdings Co Ltd – Locations And Subsidiaries 9
Head Office 9
Other Locations & Subsidiaries 9
Section 2 – Company Analysis 11
Noevir Holdings Co Ltd – Business Description 11
Noevir Holdings Co Ltd – SWOT Analysis 12
SWOT Analysis – Overview 12
Noevir Holdings Co Ltd – Strengths 12
Noevir Holdings Co Ltd – Weaknesses 13
Noevir Holdings Co Ltd – Opportunities 14
Noevir Holdings Co Ltd – Threats 15
Noevir Holdings Co Ltd – Key Competitors 16
Section 3 – Company Financial Ratios 17
Financial Ratios – Capital Market Ratios 17
Financial Ratios – Annual Ratios 18
Performance Chart 21
Financial Performance 21
Financial Ratios – Interim Ratios 22
Financial Ratios – Ratio Charts 23
Section 4 – Company’s Recent Developments 24
Aug 03, 2017: Noevir Holdings Announces Consolidated Results for the First Nine Months of the Fiscal Year Ending September 30, 201 7 24
Section 5 – Appendix 26
Ratio Definitions 26
About GlobalData 30
Contact Us 30
List of Tables
Noevir Holdings Co Ltd, Key Facts 5
Noevir Holdings Co Ltd, Key Employees 6
Noevir Holdings Co Ltd, Major Products and Services 7
Noevir Holdings Co Ltd, History 8
Noevir Holdings Co Ltd, Other Locations 9
Noevir Holdings Co Ltd, Subsidiaries 9
Noevir Holdings Co Ltd, Key Competitors 16
Noevir Holdings Co Ltd, Ratios based on current share price 17
Noevir Holdings Co Ltd, Annual Ratios 18
Noevir Holdings Co Ltd, Annual Ratios (Cont...1) 19
Noevir Holdings Co Ltd, Annual Ratios (Cont...2) 20
Noevir Holdings Co Ltd, Interim Ratios 22
Currency Codes 26
Capital Market Ratios 26
Equity Ratios 27
Profitability Ratios 27
Cost Ratios 28
Liquidity Ratios 28
Leverage Ratios 29
Efficiency Ratios 29
Noevir Holdings Co Ltd (4928)：企業の財務・戦略的SWOT分析(Noevir Holdings Co Ltd (4928) - Financial and Strategic SWOT Analysis Review)]についてメールでお問い合わせはこちらでお願いします。